from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0452/-

LFCtreatmentdescriptionclass of inhibitor

0.285

Amikacinug/mL Amikacintranslation

-0.042

Cap5-10ug/mL Capreomycintranslation

0.073

Rox10-50 ug/mL Roxithromycintranslation

-0.664

SM2-5 ug/mL Streptomycintranslation

1.185

Tet5-10 ug/mL Tetracyclinetranslation

1.567

Rif0.2-5ug/mL Rifampicintranscription

0.527

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.311

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.762

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.345

CPZ10-50 ug/mL Chlorpromazinerespiration

1.674

Clofazimine10-13 ug/mL Clofaziminerespiration

1.202

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.486

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.314

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.207

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.237

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.615

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.110

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.359

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.485

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.714

KCN5-20 ug/mL Potassium cyaniderespiration

-0.383

NaN30.2-2 mM Sodium aziderespiration

0.371

Nigericin50 uM Nigericinrespiration

0.038

TRC10-150 ug/mL Triclosanrespiration

0.934

TRZ10-25 ug/mL Thioridazinerespiration

-0.232

Valinomycin0.5-10 uM Valinomycinrespiration

0.409

ZnSO42 mM ZnSO4respiration

-0.825

menadione6-10 ug/mL Menadionerespiration

0.236

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.672

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.278

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.310

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.802

NRP_1Non-replicating persistence stage 1dosRassociated

-0.476

Amp0.2mg/mL AmpicillincellWall

-0.325

Cephalexin20-100 ug/mL CephalexincellWall

-0.012

Cerulenin0.32-5 ug/mL CerulenincellWall

0.755

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.317

EMB10-20 ug/mL EthambutolcellWall

-0.749

Eta12-40 ug/mL EthionamidecellWall

-1.211

INH0.2-0.4 ug/mL IsoniazidcellWall

0.416

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-2.092

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.899

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.392

BZA0.12 mg/mL BenzamidearomaticAmides

-0.240

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.659

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.467

H2O24 mM hydrogen peroxideDNAdamaging

-0.097

Levo10 ug/mL LevofloxacinDNAdamaging

0.054

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.872

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.370

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.272

UVUV-irradiationDNAdamaging

0.909

ARP41-4 ug/mL Antitubercular compound ARP4?

0.876

Antimycin12.5-50 ug/mL Antimycin A?

-0.525

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.073

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.375

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.388

PA8240.2-2 ug/mL PA-824?

-0.037

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.045

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

2.002

Verapamil50 uM Verapamil?

-0.748

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.187

methoxatin10-20 ug/mL Methoxatin?